Latest news with #FalseClaimsActs
Business Wire
4 days ago
- Business
- Business Wire
Getnick Law Receives Top Ranking from Chambers USA for Accomplishments Representing Plaintiffs in False Claims Act Cases
NEW YORK--(BUSINESS WIRE)--Chambers USA's recently released 2025 guide ranks Getnick Law in the top tier for firms in the United States that represent plaintiffs in False Claims Act cases. The Band 1 national ranking, Chambers' highest tier, follows Getnick Law's inclusion in the Chambers 2024 and 2025 New York Spotlight reports, which highlight the top small and medium-sized firms in the state. Since 1990, Chambers & Partners has identified and ranked the best law firms and lawyers globally. Getnick Law's Band 1 national ranking was determined after extensive feedback from lawyer and client interviews conducted by Chambers researchers, which addressed Getnick Law's practice and reputation. Getnick Law's references for the 2025 Guide included these accolades: 'Getnick Law offers complete integrity; it is a law firm you can trust.' 'Getnick Law is a leading False Claims Act law firm. It has a stellar reputation in the legal community and has a track record of success.' 'The firm's knowledge of the law and legal strategy is exemplary.' Getnick Law for decades has been a national leader representing whistleblowers under federal and state whistleblower laws and programs, including the federal and state False Claims Acts and the Internal Revenue Service, Securities and Exchange Commission, U.S. Treasury anti-money laundering and sanctions, and other whistleblower programs. 'This top ranking is a great testament to the hard work of everybody at the firm and to our exceptional clients who often must deal with challenging circumstances to bring forward these important cases,' said Neil Getnick, the managing partner of Getnick Law. Getnick Law has recovered more than $1.5 billion for taxpayers through its whistleblower cases and achieved record awards for its clients. The firm has represented whistleblowers in many groundbreaking cases, including a $750 million civil and criminal settlement with a multinational pharmaceutical company for manufacturing and selling adulterated drugs to government health plans. This resulted in the then-largest award to a single whistleblower for Getnick Law's client. Last year, Getnick Law and co-counsel represented a whistleblower in a groundbreaking $263 million tax fraud recovery from an individual taxpayer. Its client and the two other whistleblowers in the matter received a 30% award – the highest possible under the IRS Whistleblower Program. This settlement is one of the largest tax whistleblower cases ever. Getnick Law is a premier, New York-based, boutique law firm fighting fraud and promoting business integrity by representing whistleblowers under federal and state laws, conducting complex investigations and litigation, and counseling commercial clients throughout the country and internationally.
Business Wire
30-05-2025
- Business
- Business Wire
Kirby McInerney Announces CFTC Whistleblower Award
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is proud to announce that the Commodity Futures Trading Commission (the 'Commission') has awarded approximately $700,000 to a whistleblower it represented. Under the Commodity Exchange Act and the Commission's Whistleblower rules, a whistleblower who provides valuable information is entitled to between 10% and 30% of monetary sanctions collected by the Commission for commodities law violations. The Commission gave the award in recognition that the whistleblower's 'highly significant' information caused the Commission's Division of Enforcement to open an investigation and 'precisely and accurately described' illegal conduct in the commodities markets. The award was also in recognition for the 'high degree of assistance' that the whistleblower provided the Division after the investigation was opened. Ultimately, the Commission concluded that the whistleblower 'conserved substantial resources for the Commission.' 'This case underscores the degree to which whistleblowers can play a critical role in helping regulators police esoteric commodities markets,' said Kirby McInerney Co-Managing Partner David Kovel, who oversaw the case. 'While we disagree with aspects of the CFTC's determination, overall we applaud the CFTC for its support and recognition of whistleblowers, like our client, who bring this important value to the enforcement of commodities markets.' Kirby McInerney extends its gratitude to its client and to the CFTC for investigating and pursuing this case. Kirby McInerney is a New York-based law firm concentrating in whistleblower, securities, antitrust, and consumer litigation. The firm's efforts on behalf of investors, consumers, and the government have resulted in recoveries totaling billions of dollars. The firm represents whistleblowers in numerous programs, including in the SEC, CFTC, and IRS whistleblower programs and in cases under the federal and state False Claims Acts. Kirby McInerney has been involved in some of the most cutting-edge areas of commodities litigation, and represented the whistleblower who received nearly $200 million, the largest CFTC whistleblower award ever. The firm's commodity litigation experience includes cases involving the manipulation of agricultural, energy, fixed income, foreign exchange, metals, and other markets. Notably, Kirby McInerney served as co-lead counsel for a class of exchange-based plaintiffs in the high-profile In re LIBOR-Based Financial Instruments Antitrust Litig., No. 11 MD 2262 (S.D.N.Y.) and secured settlements totaling $190 million for Eurodollar Futures traders. This amount represents the largest recovery in a 'futures-only' commodities class action litigation. Kirby McInerney's CFTC Whistleblower Team is led by the firm's Co-Managing Partner, David Kovel, who was previously a commodities trader for a large financial firm. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Yahoo
30-05-2025
- Business
- Yahoo
Kirby McInerney Announces CFTC Whistleblower Award
NEW YORK, May 30, 2025--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is proud to announce that the Commodity Futures Trading Commission (the "Commission") has awarded approximately $700,000 to a whistleblower it represented. Under the Commodity Exchange Act and the Commission's Whistleblower rules, a whistleblower who provides valuable information is entitled to between 10% and 30% of monetary sanctions collected by the Commission for commodities law violations. The Commission gave the award in recognition that the whistleblower's "highly significant" information caused the Commission's Division of Enforcement to open an investigation and "precisely and accurately described" illegal conduct in the commodities markets. The award was also in recognition for the "high degree of assistance" that the whistleblower provided the Division after the investigation was opened. Ultimately, the Commission concluded that the whistleblower "conserved substantial resources for the Commission." "This case underscores the degree to which whistleblowers can play a critical role in helping regulators police esoteric commodities markets," said Kirby McInerney Co-Managing Partner David Kovel, who oversaw the case. "While we disagree with aspects of the CFTC's determination, overall we applaud the CFTC for its support and recognition of whistleblowers, like our client, who bring this important value to the enforcement of commodities markets." Kirby McInerney extends its gratitude to its client and to the CFTC for investigating and pursuing this case. Kirby McInerney is a New York-based law firm concentrating in whistleblower, securities, antitrust, and consumer litigation. The firm's efforts on behalf of investors, consumers, and the government have resulted in recoveries totaling billions of dollars. The firm represents whistleblowers in numerous programs, including in the SEC, CFTC, and IRS whistleblower programs and in cases under the federal and state False Claims Acts. Kirby McInerney has been involved in some of the most cutting-edge areas of commodities litigation, and represented the whistleblower who received nearly $200 million, the largest CFTC whistleblower award ever. The firm's commodity litigation experience includes cases involving the manipulation of agricultural, energy, fixed income, foreign exchange, metals, and other markets. Notably, Kirby McInerney served as co-lead counsel for a class of exchange-based plaintiffs in the high-profile In re LIBOR-Based Financial Instruments Antitrust Litig., No. 11 MD 2262 (S.D.N.Y.) and secured settlements totaling $190 million for Eurodollar Futures traders. This amount represents the largest recovery in a "futures-only" commodities class action litigation. Kirby McInerney's CFTC Whistleblower Team is led by the firm's Co-Managing Partner, David Kovel, who was previously a commodities trader for a large financial firm. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. View source version on Contacts Kirby McInerney LLPDavid E. Kovel, Esq. 212-371-6600https:// dkovel@ Sign in to access your portfolio
Yahoo
27-03-2025
- Business
- Yahoo
Walgreen Co. agrees to pay over $2.8 million to settle allegations of overbilling Medicaid programs
Walgreen Co. has agreed to pay more than $2.8 million to resolve allegations that it violated federal law by submitting inflated prices for certain generic medications to the Massachusetts and Georgia Medicaid programs, the U.S. Attorney said. The Massachusetts Medicaid program (MassHealth) and the Georgia Medicaid program are jointly funded and administered federal and state programs that cover medical costs, including medication costs, for persons with limited income, U.S Attorney Leah Foley said in statement. The MassHealth and the Georgia Medicaid program reimburse Walgreens' pharmacies for dispensing generic medications to beneficiaries using the lowest of four reporting price points. One of the four price points is each pharmacy's 'usual and customary price,' which is generally the amount of money the pharmacy is willing to accept for a medication on that date of service, Foley said. The United States, Massachusetts and Georgia allege that, between 2008 and 2023, Walgreens' pharmacies submitted a higher usual and customary price to the MassHealth and Georgia Medicaid programs for certain generic medications at certain times. By failing to report the correct usual and customary price, Walgreens' pharmacies allegedly caused the MassHealth and Georgia Medicaid programs to pay more for these generic medications than they should have, prosecutors said. The settlement resolves, in part, claims brought by a whistleblower under the qui tam provisions of the federal, Massachusetts, and Georgia False Claims Acts. Under all three False Claims Acts, private parties may sue on behalf of the government and receive a share of a recovery. This is a developing story. Check back for updates as more information becomes available. Download the FREE Boston 25 News app for breaking news alerts. Follow Boston 25 News on Facebook and Twitter. | Watch Boston 25 News NOW
Yahoo
27-03-2025
- Business
- Yahoo
Walgreens to pay $2.8 million in alleged Medicaid overbilling lawsuit
BOSTON — Walgreens has agreed to pay over $2.8 million in settlement agreements in violation of federal, Georgia and Massachusetts False Claim Acts. The settlement alleges Walgreen Co. inflated prices for generic medications to Georgia and Massachusetts Medicaid programs. Both the Georgia and Massachusetts Medicaid programs are jointly funded and administered programs that cover medical costs, including medication costs for people with limited income. The programs reimburse pharmacies for distributing generic medication at the lowest of four price points. One of the price points is the 'usual and customary price' which is generally the amount a pharmacy is willing to take. The lawsuit alleges that, between 2008 and 2023, Walgreens' pharmacies submitted a higher 'usual and customary price' to the MassHealth and Georgia Medicaid programs for certain generic medications at certain times. By failing to report the correct price, Walgreens' pharmacies allegedly caused both programs to pay more for generic medications than they should have. Under the Georgia, Massachusetts and federal False Claims Acts, private parties may sue on behalf of the government and receive a share of a recovery. WRBL has reached out to the Georgia Attorney General's office, but has not received a comment at this time. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
